B
Novo Nordisk A/S NVO
$128.62 $3.362.68%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)

12/31/2023 09/30/2023 06/30/2023 03/31/2023 12/31/2022
Revenue 33.71B 30.81B 28.40B 26.37B 25.03B
Total Other Revenue -- -- -- -- --
Total Revenue 33.71B 30.81B 28.40B 26.37B 25.03B
Cost of Revenue 5.19B 4.88B 4.44B 4.16B 4.02B
Gross Profit 28.52B 25.93B 23.96B 22.22B 21.00B
SG&A Expenses 8.94B 8.32B 7.98B 7.42B 7.16B
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -17.31M -76.35M -70.17M -93.69M -148.08M
Total Operating Expenses 18.62B 17.33B 16.12B 14.95B 14.32B
Operating Income 15.09B 13.48B 12.28B 11.42B 10.71B
Income Before Tax 15.19B 13.45B 11.79B 10.65B 9.79B
Income Tax Expenses 3.05B 2.60B 2.28B 2.07B 1.92B
Earnings from Continuing Operations 12.15K 10.84K 9.51K 8.58K 7.87K
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 12.15B 10.84B 9.51B 8.58B 7.87B
EBIT 15.09B 13.48B 12.28B 11.42B 10.71B
EBITDA 16.24B 14.59B 13.30B 12.36B 11.65B
EPS Basic 2.71 2.41 2.11 1.90 1.74
Normalized Basic EPS 2.15 1.90 1.66 1.50 1.38
EPS Diluted 2.70 2.41 2.11 1.89 1.73
Normalized Diluted EPS 2.14 1.89 1.66 1.50 1.37
Average Basic Shares Outstanding 17.93B 17.97B 18.02B 18.07B 18.12B
Average Diluted Shares Outstanding 17.98B 18.03B 18.08B 18.13B 18.18B
Dividend Per Share 1.36 1.00 1.00 0.86 0.86
Payout Ratio 37.90% 42.45% 41.47% 45.97% 46.63%
Weiss Ratings